Holly George

Holly George is a skilled professional in the pharmaceutical and clinical research sectors, currently serving as a Business Development Account Manager in Neurology at Evolution Research Group since November 2023. In this role, Holly acts as the primary liaison between ERG and pharmaceutical sponsors/CROs, focusing on the execution of Alzheimer's and neurology clinical trials. Previously, as the Alzheimer’s Study Initiative Lead, Holly collaborated with residential and long-term care facilities to enhance research capabilities for Alzheimer's Disease. Holly's extensive experience includes serving as a Consultant Pharmacist at Certified Consultant Pharmacists, Inc. and The Rasa Group, where educational sessions on medication use and compliance were emphasized. Earlier in the career, Holly worked at Organon Pharmaceuticals as a Specialty Pharmaceutical Sales Representative and a Medical Information Specialist, contributing to the launch of NuvaRing® and ensuring compliance with medical communications. Holly holds a BS in Pharmacy from Rutgers University and additional education from UMDNJ.